Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    20964826 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Luteinizing Hormone-Releasing Hormone Agonist Therapy and Iodine I 125 Implant in Treating Patients With Previously Untreated Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: releasing hormone agonist therapy;   Procedure: adjuvant therapy;   Procedure: neoadjuvant therapy;   Radiation: iodine I 125
2 Unknown  PSA Levels and Biopsy Samples After Implant Radiation and Hormone Therapy in Patients With Stage I or Stage II Prostate Cancer
Condition: Prostate Cancer
Interventions: Other: laboratory biomarker analysis;   Procedure: biopsy

Indicates status has not been verified in more than two years